Grace Therapeutics Inc share price logo

Grace Therapeutics Inc Share Price

NASDAQ: GRCE

Mid Cap

$3.13

-0.08

(-2.49%)

as on

Grace Therapeutics Inc Stock Performance

as on October 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $3.08
    $3.19
    downward going graph

    1.60%

    Downside

    1.92%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.75
    $4.97
    downward going graph

    44.09%

    Downside

    58.63%

    Upside

    downward going graph

Grace Therapeutics Inc share price movements today

Previous Close
$3.21
Open
$3.19
Volume
539.8K
Day's Low - High
$3.08 - $3.19
52 Week Low - High
$1.75 - $4.97

Grace Therapeutics Inc Historical Returns

1 Month Return
0 %
3 Month Return
-7.14 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Grace Therapeutics Inc Stock Fundamentals & Key Indicators

Check Grace Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$44.4M

EPS (TTM)

-1.588

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

49442100.00%

Grace Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Grace Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Grace Therapeutics Inc image
Grace Therapeutics Inc
NA$44.4MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$63.1B231.27%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$36.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$104.8B91.13%29.0431.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$60.3B-3.62%14.3531.37%

Grace Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Grace Therapeutics Inc Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:33% versus previous 30 day period

Grace Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
0
-
Gross Profit
-
0
0
0
0
0
0
0
0
Operating Income
-4
-2
-3
-3
-4
-4
-3
-3
-3
EBITDA
-2
-2
-3
-4
-4
-4
-3
-3
-3
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-3
-2
-4
-3
-4
-4
0
-3
Income Tax Expense
0
0
0
0
0
0
0
-1
-
Net Income
-4
-3
-2
-3
-2
-3
-4
0
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
7950.00%
0.00%

Grace Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Mar 2015
Mar 2016
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
0
0
0
-
-
-
-
Gross Profit
0
0
0
-
0
0
0
Operating Income
-9
-7
-16
-15
-52
-12
-16
EBITDA
-8
-2
-9
-15
-18
-11
-12
Interest Expense
0
0
0
-
-
-
-
Depreciation
-
-
0
-
0
0
0
Income Before Tax
-1
-4
-19
-10
-51
-14
-12
Income Tax Expense
-
-
-
0
-9
-1
-3
Net Income
-1
-4
-19
-9
-42
-12
-12
Net Profit Margin
-611.68%
-16777.63%
-10039.80%
0.00%
0.00%
0.00%
0.00%

Grace Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-4
-3
-2
-3
-2
-3
-4
0
-3
Operating Cash Flow
-6
-2
-1
-2
-3
-4
-4
-2
-1
Investing Cash Flow
-
0
-6
6
0
0
0
-
-
Financing Cash Flow
-
7
0
0
-
-
-
14
0
Change in Cash
-6
5
-8
4
-3
-4
-4
11
-2

Grace Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Mar 2016
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
-4
-16
-39
-25
-19
-9
-42
-12
-9
Operating Cash Flow
-4
-9
-24
-22
-14
-17
-15
-12
-14
Investing Cash Flow
6
0
-9
8
-9
-3
13
0
-
Financing Cash Flow
0
8
45
13
59
-
0
7
14
Change in Cash
1
-1
10
-2
36
-20
-2
-4
0

Insights on Grace Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, GRCE stock has moved up by 4.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 148.2% return, outperforming this stock by 156.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 69.1%

About Grace Therapeutics Inc

Grace Therapeutics, Inc. is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, and reduced side effects. Its lead clinical asset, GTx-104, is an intravenous infusion targeting aneurysmal Subarachnoid Hemorrhage (aSAH), a rare and life-threatening medical emergency in which bleeding occurs over the surface of the brain in the subarachnoid space between the brain and skull. The nanoparticle technology of GTx-104 facilitates aqueous formulation of insoluble nimodipine for a standard peripheral IV infusion. Its other pipeline includes GTX-102, which is targeted as the first potential therapy for the treatment of ataxia-telangiectasia (AT) in a pediatric population and GTx-101, which is a topical administration via a bioadhesive, film-forming polymer, for the treatment of pain associated with postherpetic neuralgia.
OrganisationGrace Therapeutics Inc
Headquarters103 Carnegie Center, Princeton, NJ, United States, 08540
CEOMr. Prashant Kohli
E-voting on sharesClick here to vote

Key Management of Grace Therapeutics Inc

Name

Title

Mr. Prashant Kohli

CEO & Director

Mr. Amresh Kumar Ph.D.

VP of Program Management

Ms. Carrie D'Andrea

VP of Clinical Operations

Mr. Robert J. DelAversano CPA

VP of Finance and Principal Financial & Accounting Officer

Dr. R. Loch MacDonald M.D., Ph.D.

Member of Scientific Advisory Board & Chief Medical Officer

FAQs

What is Grace Therapeutics Inc share price today?

Grace Therapeutics Inc share price today is $3.13 as on at the close of the market. Grace Therapeutics Inc share today touched a day high of $3.19 and a low of $3.08.

What is the 52 week high and 52 week low for Grace Therapeutics Inc share?

Grace Therapeutics Inc share touched a 52 week high of $4.97 on and a 52 week low of $1.75 on . Grace Therapeutics Inc stock price today i.e. is closed at $3.13,which is 36.96% down from its 52 week high and 78.86% up from its 52 week low.

What is Grace Therapeutics Inc's market capitalisation today?

Grace Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Grace Therapeutics Inc Stock (GRCE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Grace Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Grace Therapeutics Inc Shares that will get you 0.4792 shares as per Grace Therapeutics Inc share price of $3.13 per share as on October 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Grace Therapeutics Inc Stock (GRCE) from India?

Indian investors can start investing in Grace Therapeutics Inc (GRCE) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Grace Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Grace Therapeutics Inc share’s latest price of $3.13 as on October 18, 2025 at 1:29 am IST, you will get 3.1949 shares of Grace Therapeutics Inc. Learn more about fractional shares .